Hi-Tech Pharmaceuticals, Inc., et al., Petitioners v. Federal Trade Commission, et al.
Case Number:
23-704
Court:
Nature of Suit:
Firms
Government Agencies
-
June 03, 2024
Justices Won't Review Contempt Sanctions Against Drug Co.
The U.S. Supreme Court won't hear Hi-Tech Pharmaceuticals' challenge to the Federal Trade Commission's $40 million judgment against it for misrepresenting weight-loss drugs and violating an injunction.
-
January 11, 2024
Petition Watch: Atty 1st Amendment Rights, ERISA Remedies
The U.S. Supreme Court receives thousands of petitions for review each term, but only a few make the news. Here, Law360 looks at four petitions filed in the past two weeks that you might've missed, including questions over how attorneys' First Amendment rights are protected, the Federal Trade Commission's ability to collect civil contempt sanctions, what equitable remedies are available to plaintiffs in Employee Retirement Income Security Act lawsuits, and the cross-appeal rule.